BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 410064)

  • 1. Endogenous ligands of a putative LSD-serotonin receptor in the cerebrospinal fluid: higher level of LSD-displacing factors (LDF) in unmedicated psychotic patients.
    Mehl E; Rüther E; Redemann J
    Psychopharmacology (Berl); 1977 Aug; 54(1):9-16. PubMed ID: 410064
    [No Abstract]   [Full Text] [Related]  

  • 2. Physiological ligands of putative LSD-serotonin receptors: heterogeneity of LSD-displacing factors in human body fluids and nervous tissue.
    Mehl E; Guiard L
    Hoppe Seylers Z Physiol Chem; 1978 Apr; 359(4):539-42. PubMed ID: 649062
    [No Abstract]   [Full Text] [Related]  

  • 3. 5-HT and LSD high affinity binding sites to brain synaptosomal membranes [proceedings].
    Fillion G; Fillion MP; Jacob J; Rousselle JC
    Br J Pharmacol; 1976 Nov; 58(3):425P-426P. PubMed ID: 990612
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol.
    Peroutka SJ; Snyder SH
    Mol Pharmacol; 1979 Nov; 16(3):687-99. PubMed ID: 530254
    [No Abstract]   [Full Text] [Related]  

  • 5. Affinity chromatography for subfractionation of 5-hydroxytryptamine-, LSD-binding proteins from cerebral and nerve-ending membranes.
    Mehl E; Weber L
    Adv Biochem Psychopharmacol; 1974; 11(0):105-8. PubMed ID: 4845693
    [No Abstract]   [Full Text] [Related]  

  • 6. High-affinity binding of (3H) 5-hydroxytryptamine to brain synaptosomal membranes: comparison with (3H) lysergic acid diethylamide binding.
    Fillion GM; Rousselle JC; Fillion MP; Beaudoin DM; Goiny MR; Deniau JM; Jacob JJ
    Mol Pharmacol; 1978 Jan; 14(1):50-9. PubMed ID: 625289
    [No Abstract]   [Full Text] [Related]  

  • 7. [High affinity binding of 5-hydroxytryptamine to some membrane preparations from cattle brain. Relationship to lysergic acid diethylamide (LSD)].
    Fillion G; Fillion MP; Rousselle JC; Beaudoin D; Goiny M; Jacob J
    C R Acad Hebd Seances Acad Sci D; 1977 Mar; 284(11):979-81. PubMed ID: 405135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereospecific binding of D-lysergic acid diethylamide (LSD) to brain membranes: relationship to serotonin receptors.
    Bennett JP; snyder SH
    Brain Res; 1975 Sep; 94(3):523-44. PubMed ID: 239784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective labeling of serotonin receptors by d-[3H]lysergic acid diethylamide in calf caudate.
    Whitaker PM; Seeman P
    Proc Natl Acad Sci U S A; 1978 Dec; 75(12):5783-7. PubMed ID: 32537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors.
    Bennett JP; Snyder SH
    Mol Pharmacol; 1976 May; 12(3):373-89. PubMed ID: 6896
    [No Abstract]   [Full Text] [Related]  

  • 11. In vivo binding of 125I-LSD to serotonin 5-HT2 receptors in mouse brain.
    Hartig PR; Scheffel U; Frost JJ; Wagner HN
    Life Sci; 1985 Aug; 37(7):657-64. PubMed ID: 3160905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of 125I-lysergic acid diethylamide binding to serotonin receptors in rat frontal cortex.
    Kadan MJ; Krohn AM; Evans MJ; Waltz RL; Hartig PR
    J Neurochem; 1984 Sep; 43(3):601-6. PubMed ID: 6747625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of planarian serotonin receptor by ligand binding and PCR studies.
    Saitoh O; Yuruzume E; Nakata H
    Neuroreport; 1996 Dec; 8(1):173-8. PubMed ID: 9051775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [125I]LSD labels 5-HT1C recognition sites in pig choroid plexus membranes. Comparison with [3H]mesulergine and [3H]5-HT binding.
    Hoyer D; Srivatsa S; Pazos A; Engel G; Palacios JM
    Neurosci Lett; 1986 Sep; 69(3):269-74. PubMed ID: 3763057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of [3H]LSD with serotonin receptors in human brain.
    Cross AJ
    Eur J Pharmacol; 1982 Aug; 82(1-2):77-80. PubMed ID: 7128680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of [3H]lysergic acid diethylamide binding to a 5-hydroxytryptamine receptor on human platelet membranes.
    Geaney DP; Schächter M; Elliot JM; Grahame-Smith DG
    Eur J Pharmacol; 1984 Jan; 97(1-2):87-93. PubMed ID: 6698111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockage of LSD binding at its high affinity site on synaptosomal membranes by 1-methyl-1,2,5,6-tetrahydropyridine-N,N-diethyl- carboxamide.
    Christian ST; McClain LD; Morin RD; Benington F
    Experientia; 1975 Aug; 31(8):910-11. PubMed ID: 125655
    [No Abstract]   [Full Text] [Related]  

  • 18. 125I-LSD: a high sensitivity ligand for serotonin receptors.
    Hartig PR; Kadan MJ; Evans MJ; Krohn AM
    Eur J Pharmacol; 1983 May; 89(3-4):321-2. PubMed ID: 6873167
    [No Abstract]   [Full Text] [Related]  

  • 19. N1-methyl-2-[125I]LSD ([125I]MIL), a preferred ligand for serotonin 5-HT2 receptors.
    Hoffman BJ; Karpa MD; Lever JR; Hartig PR
    Eur J Pharmacol; 1985 Mar; 110(1):147-8. PubMed ID: 4007051
    [No Abstract]   [Full Text] [Related]  

  • 20. Autoradiographic localization and characterization of [125I]lysergic acid diethylamide binding to serotonin receptors in Aplysia.
    Kadan MJ; Hartig PR
    Neuroscience; 1988 Mar; 24(3):1089-102. PubMed ID: 3380298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.